GALNT16

Across TCGA pan-cancer cohorts, GALNT16 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated GALNT16 data layer compared with 29 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher GALNT16 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated GALNT16 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC and PDAC are the cancer types where GALNT16 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.976	0.817	.007	6	view →
PDAC	DFS	Quartile	II,III,IV	0.301	0.718	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

GALNT16–UCEC (OS)

Open the UCEC breakdown →